Highly Promising an Anti-Cancer Drugs : Metal Complex Bearing Sulfur Chelating Ligand, A Hypothetical Design
Abstract
In anticancer chemotherapy, drug targeting and delivery methods depend on agents with selective access to cancer cells to deliver drugs to the target, and approaches to finding such agents often depend on novel design strategies employing bioactive vectors. Platinum-based complexes are extremely important drugs for the treatment of cancer. Recently synthesized complexes of Pt (IV) have been shown to have several advantages, such as they are safer, can be used orally, are highly anti-cancer effective, there is no cross-resistance to cisplatin, and their effectiveness is compared with commonly used Pt (II) compounds such as cisplatin and oxaliplatin. A molecular mimicry model for the generation of new active drugs may be synthesized by the 3,5-ditert-butyl-2-hydroxy-benzylaminocysteine (DTHBAC) where a cysteine group and two tertiary butyl groups attached to the phenol aromatic ring can be coordinated with platinum. This appropriate ligand with the platinum complex is fit for the anticancer drug. Based on the present modeling, it can be recommended in the management of patients, and from this perspective, the status of the platinum anticancer drug field will develop over the next decade. Moreover, the authors have no doubt that this will benefit patients in the future and will be widely used in cancer treatment for years to come.
Keywords: Drug design, Anti-cancer, Cisplatin, Complex, Chelate.
Keywords:
Drug design, Anti-cancer, Cisplatin, Complex, ChelateDOI
https://doi.org/10.22270/jddt.v12i4.5437References
Rajeswari J, Renu K, Pavana GS, Avinash TR, Gopal P. Alterations in cell-extracellular matrix interactions during progression of cancers. Int J Cell Biol. 2012; Article ID 219196. https://doi.org/10.1155/2012/219196
Herszényi L, Hritz I, Lakatos G, Varga MZ, Tulassay Z. The behavior of matrix metalloproteinases and their inhibitors in colorectal cancer. Int J Mol Sci. 2012; 13:13240-13263. https://doi.org/10.3390/ijms131013240
José MPM, Miguel AF, Carlos A, Carmen NR. Current status of the development of trans-platinum antitumor drugs. Cri Rev in Onco/Hemato, 2000; 35(2):109-20. https://doi.org/10.1016/S1040-8428(00)00053-6
Pavel S, Igor P, Zdeněk T, Ján V. N6-benzyladenosine derivatives as novel n-donor ligands of platinum(ii) dichlorido complexes. Molecules. 2013; 18:6990-7003. https://doi.org/10.3390/molecules18066990
Martínez R, Angel CS, Ma T, Ramírez A. Synthesis and cytotoxic evaluation of new (4, 5, 6, 7-tetrahydro-indol-1-yl)-3-R-propionic acids and propionic acid ethyl esters generated by molecular mimicry. Bio med chem. 2007; 15(11):3912-3918. https://doi.org/10.1016/j.bmc.2006.12.018
Yan YK, Michael M, Abraha H, Peter JS. Organometallic chemistry, biology and medicine: ruthenium arene anticancer complexes. Chem comm. 2005; 38:4764-4776. https://doi.org/10.1039/b508531b
Xiaojuan Z, Chuanchuan H, Yun S, Xiaoguang L, Yan C, Chen C, Ruicong Y, Ting F, Tan Y, Yao L, Jun L, Xiang M, Guangya X. A smart O2-generating nanocarrier optimizes drug transportation comprehensively for chemotherapy improving. Act Pharm Sin B. 2021; 11(11):3608-3621. https://doi.org/10.1016/j.apsb.2021.04.021
Petra B, Ferenc F, István S. Mannich base-connected syntheses mediated by ortho-quinone methides beilstein. J Org Chem. 2018; 14:560-575. https://doi.org/10.3762/bjoc.14.43
Weinert EE, Dondi R, Colloredo MS, Frankenfield KN, Mitchell CH, Freccero M, Rokita SE. Substituents on quinone methides strongly modulate formation and stability of their nucleophilic adducts, J Am Chem Soc. 2006; 128:11940-11947. https://doi.org/10.1021/ja062948k
Ahmed MM. Synthesis and biochemical study on the effect of a novel gallium complex on tumor cell invasion and matrix metalloproteinase activity In vitro (2017).
Thompson KH, Chris O. Metal complexes in medicinal chemistry: New vistas and challenges in drug design. Dalton trans. 2006; 6:761-764. https://doi.org/10.1039/B513476E
Thompson KH, Chris O. Boon and bane of metal ions in medicine. Sci. 2003; 300(5621):936-939. https://doi.org/10.1126/science.1083004
Langer P. Martin S. Regio‐ and stereoselective synthesis of γ‐alkylidenebutenolides by cyclization of dilithiated 1,3‐dicarbonyl compounds with N,N′‐dimethoxy‐N, N′‐dimethylethane‐diamide, Angew Chem Int Ed. 1999; 38(12):1803-1805. https://doi.org/10.1002/(SICI)1521-3773(19990614)38:12<1803::AID-ANIE1803>3.0.CO;2-5
Jansen BAJ, Jaap B, Jan R. Glutathione induces cellular resistance against cationic dinuclear platinum anticancer drugs. J Inorga biochem. 2002; 89(3-4):197-202. https://doi.org/10.1016/S0162-0134(02)00381-1
Teuben JM, Stella SB, Jan R. Intramolecular migration of co-ordinated platinum from a sulfur to N7 in the nucleopeptide Met-d(TpG)(5′-O-methioninate-N-ylcarbonylthymidine 2′-deoxyguanosine monophosphate). J Chem Soc. Dal Trans. 1997; 21:3979-3980. https://doi.org/10.1039/a703600k
Teuben JM, Mireia RZ, Jan R. Glutathione readily replaces the thioether on platinum in the reaction with [Pt(dien)(GSMe)]2+(GSMe=S-methylated glutathione); a model study for cisplatin-protein interactions, J.Chem. Soc. Dal Trans. 2000; 3:369-372. https://doi.org/10.1039/a908135f
Rauter H, Roberto DD, Ernesto M, Ambrogio O, Yun Q, Nicholas F. Selective platination of biologically relevant polyamines, linear coordinating spermidine and spermine as amplifying linkers in dinuclear platinum complexes. Inorga Chem.1997; 36(18):3919-3927. https://doi.org/10.1021/ic9701827
Lipshutz H, Yamamoto Y. The special issue of coinage metals in organic synthesis, Eds, B. Chem Rev. 2008; 108:2793-2795. https://doi.org/10.1021/cr800415x
Fusi F, Donata I, Giampietro S, Maria F. 3,5-Di-t-butylcatechol (DTCAT) as an activator of rat skeletal muscle ryanodine receptor Ca2+ channel (RyRC). Bio pharma. 2005; 69(3):485-491. https://doi.org/10.1016/j.bcp.2004.10.013
Ravikumar B, Aittokallio T. Improving the efficacy-safety balance of polypharmacology in multi-target drug discovery. Exp Opin Drug Met. 2018; 13:179 -192. https://doi.org/10.1080/17460441.2018.1413089
Alcaro S, Bolognesi ML, Garcı'SAT, Rapposelli S. Multi-target-directed ligands (MTDL) as challenging research tools in drug discovery: from design to pharmacological evaluation. Front Chem. 2019; 7:71. https://doi.org/10.3389/fchem.2019.00071
Vasilii G, Serghei S, Victor T, Aurelian G. Synthesis and antitumor activity of copper, nickel and cobalt coordination compounds with 1-(2-hydroxyphenyl) ethanone N(4)-allyl-3-thiosemicarbazone. Studia Univer Moldaviae. 2015; 1:1814-3237
Published
Abstract Display: 393 
PDF Downloads: 534 PDF Downloads: 48 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.